Evoke SCS
Device Spinal Cord Stimulation
General payments
$2,318,376
Research payments
$1,963,546
Through program year 2024, $2,318,376 in general payments and $1,963,546 in research payments were reported against Evoke SCS (Spinal Cord Stimulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $414,063 | 162 |
| 2023 | General | $1,728,431 | 6,032 |
| 2023 | Research | $593,260 | 186 |
| 2022 | General | $588,907 | 1,126 |
| 2022 | Research | $930,206 | 240 |
| 2021 | Research | $26,018 | 3 |
| 2020 | General | $620 | 14 |
| 2019 | General | $417 | 7 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 64 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
7,179 general · 591 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.